Company intelligence / Profile preview

Integral Neurotechnologies

San Francisco / South San Francisco, California, United Statesintegralneuro.com ↗

Ownership: Private
Employees: ~7
Development stage: Preclinical

Overview

The company’s first device—a miniaturized, implanted deep-brain interface—aims to provide unprecedented capabilities for recording and modulating neural activity in patients with severe neurological or psychiatric conditions. No clinical results have been published yet.[1] The device also serves as a unique discovery platform to develop new treatments for brain disorders.[1]

Therapeutic areas: Neurology
Modalities: Implanted neurostimulation devicesdeep-brain interfacesneuromodulation technology
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Integral Neurotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integral Neurotechnologies.

Explore the full profile